论文信息 - Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study - 字舞流文

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

N. Goel | V. Strand | J. Vencovský | First | R. V. van Vollenhoven | R. Fleischmann | J. Box | A. Innes | D. Borenstein | G. Coteur | H. Brezinschek | R. Vollenhoven | H. Brezinschek | J. Vencovský | Online Ard